Table 1.
Study intervention | Baseline (visit 1) | Intervention (visit 2) | 6 weeks (visit 3) | 12 Weeks (visit 4; remote) | 26 weeks (visit 5; remote) |
---|---|---|---|---|---|
Timeframe | -0 to ± 1 week | ±3 to ± 5 days | ± 1 week | ±1 week | ±1 week |
Eligibility assessment | X | ||||
Consent | X | ||||
Radiograph of shoulder | X | ||||
Randomization | X | ||||
Trial treatment delivery (CSI vs CSI + HD) | X | ||||
OSS | X | X | X | X | |
Range of motion | X | X | X | X | |
EQ-5D-5L | X | X | X | X | |
Resource use | X | X | X | X | |
Participant experience questionnaire | X |
CSI, corticosteroid injection; EQ-5D-5L, EuroQol five-dimension five-level questionnaire; HD, hydrodilation; OSS, Oxford Shoulder Score.